Zobrazeno 1 - 10 of 162 pro vyhledávání: '"Gorodnova TV"'
1
Akademický článek
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
Autor: Sokolenko AP; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia. annasokolenko@mail.ru.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, 194100, Russia. annasokolenko@mail.ru., Gorodnova TV; Department of Oncogynecology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Bizin IV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Kuligina ES; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Kotiv KB; Department of Oncogynecology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Romanko AA; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Ermachenkova TI; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Ivantsov AO; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Preobrazhenskaya EV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Sokolova TN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia., Broyde RV; City Cancer Center, Saint-Petersburg, 197758, Russia., Imyanitov EN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, 197758, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, 194100, Russia.; Department of Oncology, I.I. Mechnikov North-Western Medical University, Saint-Petersburg, 191015, Russia.
Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Sep; Vol. 88 (3), pp. 439-450. Date of Electronic Publication: 2021 Jun 02.
Zobrazit plný text záznamu
2
Akademický článek
Molecular profiles of BRCA1-associated ovarian cancer treated by platinum-based therapy: Analysis of primary, residual and relapsed tumors.
Autor: Sokolenko AP; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, Russia., Bizin IV; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Preobrazhenskaya EV; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, Russia., Gorodnova TV; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Ivantsov AO; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Iyevleva AG; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, Russia., Savonevich EL; Department of Obstetrics and Gynecology, Grodno State Medical University, Grodno, Belarus., Kotiv KB; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Kuligina ES; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Imyanitov EN; Department of Tumour Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, Russia.
Publikováno v: International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 1879-1888. Date of Electronic Publication: 2019 Nov 29.
Zobrazit plný text záznamu
3
Akademický článek
Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer.
Autor: Gorodnova TV; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia., Sokolenko AP; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia. annasokolenko@mail.ru.; St.-Petersburg Pediatric Medical University, 194100, St.-Petersburg, Russia. annasokolenko@mail.ru., Kondratiev SV; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia., Kotiv KB; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia., Belyaev AM; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia., Berlev IV; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia., Imyanitov EN; N.N. Petrov National Medical Research Center of Oncology, Leningradskaya, 68, Pesochny-2, 197758, St.-Petersburg, Russia.; St.-Petersburg Pediatric Medical University, 194100, St.-Petersburg, Russia.; I.I. Mechnikov North-Western Medical University, 191015, St.-Petersburg, Russia.
Publikováno v: Investigational new drugs [Invest New Drugs] 2020 Dec; Vol. 38 (6), pp. 1872-1878. Date of Electronic Publication: 2020 Jun 26.
Zobrazit plný text záznamu
4
Akademický článek
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
Autor: Gorodnova TV; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia., Sokolenko AP; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia.; St.-Petersburg Pediatric Medical University, 194100, Saint-Petersburg, Russia., Kotiv KB; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia., Sokolova TN; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia., Ivantsov AO; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia.; St.-Petersburg Pediatric Medical University, 194100, Saint-Petersburg, Russia., Guseynov KD; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia., Nekrasova EA; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia., Smirnova OA; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia., Berlev IV; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia.; I.I. Mechnikov North-Western Medical University, 195067, St.-Petersburg, Russia., Imyanitov EN; N.N. Petrov Institute of Oncology, 197758, Saint-Petersburg, Russia. evgeny@imyanitov.spb.ru.; St.-Petersburg Pediatric Medical University, 194100, Saint-Petersburg, Russia. evgeny@imyanitov.spb.ru.; I.I. Mechnikov North-Western Medical University, 195067, St.-Petersburg, Russia. evgeny@imyanitov.spb.ru.
Publikováno v: Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2021 Feb 03; Vol. 19 (1), pp. 14. Date of Electronic Publication: 2021 Feb 03.
Zobrazit plný text záznamu
5
Akademický článek
Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
Autor: Sokolenko AP; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia. annasokolenko@mail.ru.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, Russia. annasokolenko@mail.ru., Sokolova TN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia., Ni VI; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Preobrazhenskaya EV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia., Iyevleva AG; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia., Aleksakhina SN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia., Romanko AA; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, Russia., Bessonov AA; Department of Mammology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Gorodnova TV; Department of Oncogynecology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Anisimova EI; Leningrad Regional Cancer Hospital, St.-Petersburg, Russia., Savonevich EL; Department of Obstetrics and Gynecology, Grodno State Medical University, Grodno, Belarus., Bizin IV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Stepanov IA; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Krivorotko PV; Department of Mammology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Berlev IV; Department of Oncogynecology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia., Belyaev AM; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Department of Oncology, I.I. Mechnikov North-Western Medical University, Saint-Petersburg, Russia., Togo AV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia., Imyanitov EN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, Russia.; Department of Oncology, I.I. Mechnikov North-Western Medical University, Saint-Petersburg, Russia.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Nov; Vol. 184 (1), pp. 229-235. Date of Electronic Publication: 2020 Aug 09.
Zobrazit plný text záznamu
6
Akademický článek
Gastric Cancer in BRCA1 Germline Mutation Carriers: Results of Endoscopic Screening and Molecular Analysis of Tumor Tissues.
Autor: Avanesyan AA; Department of Endoscopy, City Cancer Center, Saint Petersburg, Russian Federation.; Department of Endoscopy, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Sokolenko AP; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation, annasokolenko@mail.ru.; Department of Medical Genetics, St. Petersburg Pediatric Medical University, Saint Petersburg, Russian Federation, annasokolenko@mail.ru., Ivantsov AO; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Kleshchev MA; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Maydin MA; Department of Carcinogenesis and Oncogerontology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Bizin IV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Raskin GA; A.M. Granov Center for Radiology and Surgical Technologies, Saint Petersburg, Russian Federation., Shelekhova KV; Department of Pathology, City Cancer Center, Saint Petersburg, Russian Federation., Gorodnova TV; Department of Oncogynecology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Bessonov AA; Department of Mammology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Anisimova EI; Leningrad Regional Oncology Hospital, Saint Petersburg, Russian Federation., Volynshchikova OA; Department of Clinical Management and Control, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Romanko AA; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Ni VI; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Broyde RV; Department of Endoscopy, City Cancer Center, Saint Petersburg, Russian Federation., Tkachenko OB; Department of Endoscopy, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Whitehead AJ; Medicine Internal Medicine Residency Program, The University of Illinois College of Medicine, Chicago, Illinois, USA., Scherbakov AM; Department of Endoscopy, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation., Imyanitov EN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation.; Department of Medical Genetics, St. Petersburg Pediatric Medical University, Saint Petersburg, Russian Federation.; Department of Oncology, I.I. Mechnikov North-Western Medical University, Saint Petersburg, Russian Federation.
Publikováno v: Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2020; Vol. 87 (6), pp. 367-374. Date of Electronic Publication: 2020 Nov 06.
Zobrazit plný text záznamu
7
Akademický článek
Principles of clinical management of ovarian cancer.
Autor: Gorodnova TV; Department of Gynecology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia. t.gorodnova@mail.ru., Sokolenko AP; Department of Tumor Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Kuligina E; Department of Tumor Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Berlev IV; Department of Gynecology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Imyanitov EN; Department of Tumor Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.
Publikováno v: Chinese clinical oncology [Chin Clin Oncol] 2018 Dec; Vol. 7 (6), pp. 56.
Zobrazit plný text záznamu
8
Akademický článek
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.
Autor: Gorodnova TV; N.N. Petrov Institute of Oncology., Kotiv KB; N.N. Petrov Institute of Oncology., Ivantsov AO; N.N. Petrov Institute of Oncology., Mikheyeva ON; Leningrad Regional Oncological Dispensary., Mikhailiuk GI; Leningrad Regional Oncological Dispensary., Lisyanskaya AS; City Oncological Dispensary., Mikaya NA; N.N. Petrov Institute of Oncology., Guseynov KD; N.N. Petrov Institute of Oncology., Bondarev NE; N.N. Petrov Institute of Oncology., Matveyeva NS; N.N. Petrov Institute of Oncology., Nekrasova EA; N.N. Petrov Institute of Oncology., Sidoruk AA; N.N. Petrov Institute of Oncology., Roman LD; Leningrad Regional Oncological Dispensary., Manikhas GM; City Oncological Dispensary., Belyaev AM; N.N. Petrov Institute of Oncology., Sokolenko AP, Berlev IV; N.N. Petrov Institute of Oncology., Imyanitov EN
Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2018 Oct; Vol. 28 (8), pp. 1498-1506.
Zobrazit plný text záznamu
10
Akademický článek
Detection of BRCA1 gross rearrangements by droplet digital PCR.
Autor: Preobrazhenskaya EV; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Bizin IV; Peter the Great St.-Petersburg Polytechnic University, St.-Petersburg, Russia., Kuligina ES; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Shleykina AY; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Suspitsin EN; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; St.-Petersburg State Pediatric Medical University, St.-Petersburg, Russia., Zaytseva OA; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Anisimova EI; Leningrad Regional Oncology Center, St.-Petersburg, Russia., Laptiev SA; Pavlov First St.-Petersburg State Medical University, St.-Petersburg, Russia., Gorodnova TV; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Belyaev AM; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Imyanitov EN; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; St.-Petersburg State Pediatric Medical University, St.-Petersburg, Russia.; Pavlov First St.-Petersburg State Medical University, St.-Petersburg, Russia.; I.I. Mechnikov North-Western Medical University, St.-Petersburg, Russia., Sokolenko AP; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia. annasokolenko@mail.ru.; St.-Petersburg State Pediatric Medical University, St.-Petersburg, Russia. annasokolenko@mail.ru.; Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, St.-Petersburg, Russia, 197758. annasokolenko@mail.ru.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Oct; Vol. 165 (3), pp. 765-770. Date of Electronic Publication: 2017 Jun 27.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje